What you should know:
1. The company sold 3,432,000 shares of stock and common share purchase warrants for $0.19 per unit to close the tranche.
2. Aurora Spine will use the new funds for general corporate purposes.
3. Each unit will be exercisable 36 months after the issuance date for a cost of $0.34 per unit.
More articles on devices:
Drs. Scott Blumenthal, Richard Guyer & more: 6 Texas Back spine surgeons reflect on 20 years of artificial disc replacement
Zimmer Biomet sued for $2.6M by Mexico’s health agency
Evonik launches new material for 3D-printed spine, orthopedic implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.